Table 2 Clinical characteristics of the enrolled patients with gastrointestinal symptoms of long COVID-19 after 3Â months of follow-up and healthy controls
Characteristic | COVID-19 | Healthy control |
|---|---|---|
Male, n (%) | 27(60) | 13(52) |
Female, n (%) | 18(40) | 12(48) |
Age, year | 40.5(23–68) | 35.6(23–56) |
Hypertension, n (%) | 10(22.2) | 3(12) |
Diabetes mellitus, n (%) | 5(11.1) | 2(8) |
Hyperlipidaemia, n (%) | 7(15.5) | 4(16) |
Duration of hospitalization (days) | 9.6(5–17) |  |
Symptoms at admission, n (%) Fever | 31(68.9) | Â |
Gastrointestinal symptoms, n (%) | ||
 Diarrhea | 6(13.3) |  |
 Taste disorder | 28(62.2) |  |
Respiratory symptoms, n (%) | ||
 Cough | 17(37.8) |  |
 Rhinorrhea (runny nose) | 23(51.1) |  |
Gastrointestinal symptom of Long COVID-19, n (%) | ||
 Decreased appetite | 30(66.7) |  |
 Diarrhea | 17(37.8) |  |
 Xerostomia | 10(22.2) |  |
 Taste disorder | 5(11.1) |  |
 Emaciation | 5(11.1) |  |
 Abdominal pain | 3(6.7) |  |